X4 Pharmaceuticals (XFOR) Misses Q2 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. ABBV
5. CL
6. TFII
7. LYB
8. MRVL
9. NVT
10. SPY

Go back to X4 Pharmaceuticals (XFOR) Misses Q2 EPS by 4c

X4 Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update

July 30, 2020 8:00 AM EDT

Presentation of positive clinical data at EHA 2020 supporting the ongoing Phase 3 trial in WHIM syndrome

Initial data expected later this year from Phase 1b clinical trial in Waldenströms macroglobulinemia

Conference call today at 8:30 a.m. ET

CAMBRIDGE, Mass., July 30, 2020 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals,... More